Prescription trends in end of life Cancer Patients: An Observational Study
Not Applicable
Completed
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2023/09/057783
- Lead Sponsor
- Dr V Divya Sai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 220
Inclusion Criteria
Terminally Ill Cancer patients
Exclusion Criteria
Less than 12 years of age, those who have not consented for End of life care
Unrelated sudden deaths which are not due to cancer
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the prescription changes in terminally ill cancer patients at the time of their admission and after palliative interventionTimepoint: September 2023- September 2024
- Secondary Outcome Measures
Name Time Method To Assess the symptom burden in terminally ill cancer patientsTimepoint: September 2023- September 2024